Paasa Logo
Eli Lilly and Company logo
LLYNYSEMarket openCloses 4:00pm ET

Eli Lilly and Company

$1,174.37Last updated
-$7.53 (0.64%)Past day
Timezone

Eli Lilly and Company (NYSE: LLY) is trading at $1,174.37, about ₹1,12,763 at today's USD/INR rate, as of 25 Sep 2026, 9:51 AM ET, down 0.64% today. Indian residents can buy Eli Lilly and from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:$1,183.75
Previous close:$1,181.89
Volume:193.66K

Today's low

$1,173.33

Today's high

$1,190.00

52 week low

$716.08

52 week high

$1,292.65

LLY opened at $1,183.75, closed previously at $1,181.89, and has traded between $716.08 and $1,292.65 over the past 52 weeks.

About

Eli Lilly and Company is a prominent global pharmaceutical firm dedicated to the research, development, and commercialization of human medicines across the world. Its therapeutic offerings include a comprehensive suite of diabetes medications. This encompasses various insulin formulations like Basaglar, the Humalog family (e.g., Mix 75/25, U-100, U-200, Mix 50/50), insulin lispro products (including protamine and mix 75/25), and the Humulin line (e.g., 70/30, N, R, U-500). Furthermore, Eli Lilly provides specialized treatments for type 2 diabetes, such as Jardiance, Trajenta, and Trulicity. In oncology, Eli Lilly offers a robust portfolio targeting various cancers. These include Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza, indicated for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal and various head and neck cancers; Retevmo, used in metastatic NSCLC, medullary thyroid, and other thyroid cancers; Tyvyt for relapsed or refractory classic Hodgkin's lymphoma and non-squamous NSCLC; and Verzenio, prescribed for HR+, HER2- metastatic breast cancer, node-positive, and early breast cancer. For autoimmune and inflammatory conditions, the company markets Olumiant for rheumatoid arthritis, and Taltz, which addresses plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis. Addressing neurological and pain management needs, Eli Lilly provides Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain. Emgality is available for migraine prevention and episodic cluster headaches, while Zyprexa treats schizophrenia, bipolar I disorder, and aids in bipolar maintenance. Other significant products include Bamlanivimab and etesevimab, along with Bebtelovimab, both developed for COVID-19. Cialis is offered for erectile dysfunction and benign prostatic hyperplasia, and Forteo is available for osteoporosis. Eli Lilly actively engages in strategic collaborations with numerous partners, including Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Established in 1876, Eli Lilly and Company maintains its corporate headquarters in Indianapolis, Indiana.

Country
US
CEO
David A. Ricks
Exchange listed on
NYSE
Industry
Drug Manufacturers - General
Base currency
USD
Full Time Employees
50,000
Sector
Healthcare
IPO date
01/06/1972

Key statistics

Avg. volume

2.82M

Market cap

$1.11T

P/E Ratio

39.29

Price-to-sales ratio

13.88

Enterprise value

$1.15T

Free cash flow yield

1.81%

Debt-to-equity ratio

1.62

Return on equity

92.58%

ROIC

31.00%

Beta

0.50

Dividend yield

0.57%

Last dividend

$6.69

Financial overview

Revenue

$65.18B

Earnings per share

$23.07

Free cash flow

$8.97B

Net profit margin

33.53%

Gross margin

83.40%

EBITDA

$31.69B

Revenue growth

44.70%

Similar securities

This is not an investment recommendation

How to buy Eli Lilly and from India

Indian residents can buy Eli Lilly and shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.

  3. Search for Eli Lilly and and place an order

    Find Eli Lilly and by name or by its ticker, LLY, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Eli Lilly and trades 7:00 pm – 1:30 am IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your Eli Lilly and position in USD and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.

Read the full guide: how to invest in Eli Lilly and from India

Trading and taxes when buying Eli Lilly and from India

Trading and limits

Trading hours
9:30 am – 4:00 pm ET
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
Slab rateDividends are taxed at your slab rate in India. The US withholds tax on dividends paid to Indian residents at the treaty rate; Paasa files Form W-8BEN for you, and the tax withheld can generally be claimed as a credit in India. Eli Lilly and’s current yield is 0.57%.Dividend tax explained
US estate tax
May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator

Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

FAQs

Can Indian residents buy Eli Lilly and stock?

Yes. Eli Lilly and (LLY) has been listed on the New York Stock Exchange since 1972, in the Drug Manufacturers - General industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

How much does one Eli Lilly and share cost in rupees?

One Eli Lilly and share is $1,174.37 — about ₹1,12,763 at a USD/INR rate of 96.02 on 24 Sep 2026. Both the Eli Lilly and price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying Eli Lilly and from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

Can I buy Eli Lilly and with less than the price of one share?

Yes. A whole Eli Lilly and share is $1,174.37, but there is no minimum trade size: you enter a rupee or dollar amount and receive the matching fraction.

How are gains on Eli Lilly and shares taxed in India?

The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Eli Lilly and price. Paasa issues a capital-gains statement for your return.

Does Eli Lilly and pay a dividend, and how is it taxed in India?

Yes. Eli Lilly and pays a dividend and the current yield is 0.57%; the last declared dividend was $6.69 per share, about ₹642.37. Dividends are taxed at your slab rate in India. The US withholds tax on dividends paid to Indian residents at the treaty rate; Paasa files Form W-8BEN for you, and the tax withheld can generally be claimed as a credit in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.

When can I trade Eli Lilly and from India?

The New York Stock Exchange trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.

Is there estate or inheritance tax on Eli Lilly and shares held from India?

US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.

Do I have to declare Eli Lilly and shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Eli Lilly and holding, its cost and its closing value.

How do I sell Eli Lilly and and bring the money back to India?

You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.